NCT01287182已完成3 期
Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
Omicron Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- to evaluate the effectiveness of Ateronon in inhibiting atherogenic lipid oxidation in patients with demonstrated coronary disease
研究概览
简要总结
This is a trial of Ateronon in Patients with Coronary Disease to Evaluate its Effectiveness in Assessing the Risk Factors of Atherosclerosis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 35 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Men and Women with demonstrated Coronary Disease
- •AtheroAbzyme positive during screening process
- •Elevated Total Cholesterol
- •Willingness to take study nutritional supplement once a day for 3 months
排除标准
- •Women who are pregnant, nursing or intend pregnancy during the period of treatment
- •Known milk, soy or whey allergy
研究组 & 干预措施
Ateronon
Active Comparator
干预措施: Ateronon (Drug)
结局指标
主要结局
to evaluate the effectiveness of Ateronon in inhibiting atherogenic lipid oxidation in patients with demonstrated coronary disease
时间窗: Baseline and 3 months
次要结局
- to evaluate the potential effectiveness of Ateronon in lowering pulse rate as well systolic and diastolic blood pressure in patients with demonstrated coronary disease(Baseline and 3 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart DiseaseCoronary Heart DiseaseNCT00939237Brigham and Women's Hospital213
已完成
不适用
Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on OutcomesAngina, UnstableNCT00222352University of Cincinnati2,000
已完成
2 期
BIOHELIX-I Bare Metal Stent StudyCoronary Arteries DiseaseNCT01612767Biotronik, Inc.329
招募中
1 期
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery SubjectsAtrial Fibrillation, PostoperativeNCT06730828Helios Cardio Inc.80
Unknown
4 期
Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant PatientsCoronary AtherosclerosisInflammationCoronary Heart DiseaseNCT00155350National Taiwan University Hospital120